Outcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy: The M.D. Anderson Cancer Center Experience
详细信息 查看全文
- 作者：Philip L. Ho ; M.D.a ; Daniel L. Willis ; M.D.a ; Jeevitha Patil ; B.A.a ; Lianchun Xiao ; M.S.b ; Stephen B. Williams ; M.D.a ; Jonathan J. Melquist ; M.D.a ; Karen Tart ; B.A.a ; Sahil Parikh ; B.A.a ; Jay B. Shah ; M.D.a ; Scott E. Delacroix ; M.D.c ; Neema Navai ; M.D.a ; Arlene Siefker-Radtke ; M.D.d ; Colin P. Dinney ; M.D.a ; Louis L. Pisters ; M.D.a ; Ashish M. Kamat ; M.D.a ; akamat@mdanderson.org" class="auth_mail" title="E-mail the corresponding author
- 关键词：Bladder cancer ; Node-positive disease ; Surgical consolidation ; Preoperative chemotherapy ; Multimodality treatment approach
- 刊名：Urologic Oncology: Seminars and Original Investigations
- 出版年：2016
- 出版时间：February 2016
- 年：2016
- 卷：34
- 期：2
- 页码：59.e1-59.e8
- 全文大小：445 K
文摘
- •
Node positivity after preoperative chemotherapy carries a poor prognosis.
- •
Multimodality treatment can result in a 66% 5-year CSS rate for patients rendered as having pN0 category disease.
- •
Retroperitoneal lymph node dissection can prevent site-specific recurrences.